"With this continued progress, we believe we are well positioned to complete enrollment in the NEPHRO CRRT Study this year and file the PMA for a targeted potential approval of Niyad in 2027" (CEO & ...
VeroSCORE is powered by Veros ' extensive experience in data analytics and valuations. With distinct insight into the exact requirements for a submission-ready appraisal, VeroSCORE has also served as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results